Andrew Remppis

7.9k citations

102 papers · 6.1k indexed · 2 hit papers · h-index 40

Impact in

Cardiology and Cardiovascular Medicine top 0.5%
- Acute Myocardial Infarction Research
- Cardiac electrophysiology and arrhythmias
- Heart Failure Treatment and Management
- Cardiovascular Effects of Exercise
- Viral Infections and Immunology Research
Clinical Biochemistry top 0.5%
- Advanced Glycation End Products research

Papers in

Cardiology and Cardiovascular Medicine 71
- Heart Failure Treatment and Management 31
- Cardiac electrophysiology and arrhythmias 19
- Cardiac pacing and defibrillation studies 14
- Acute Myocardial Infarction Research 9
- Cardiovascular Effects of Exercise 8
Family Practice 5

Co-authors: Hugo A. Katus Thomas Scheffold K W Diederich Wolfgang M. Kuebler Patrick Most Sven T. Pleger Walter J. Koch Margit Müller-Bardorff
Journals: Clinical Research in Cardiology (5 papers)Circulation (5 papers)Clinical Chemistry (5 papers)European Heart Journal (4 papers)International Journal of Cardiology (4 papers)
Partner nations: Germany United States Switzerland

In The Last Decade

Andrew Remppis

98 papers receiving 5.9k citations

Hit Papers

align trajectories log scale

High-Mobility Group Box-1 in Ischemia-Reperfusion Injury of the Heart 2008 · 527 citations

Peers

Countries citing papers authored by Andrew Remppis

Since Specialization

Citations

This map shows the geographic impact of Andrew Remppis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Remppis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Remppis more than expected).

Fields of papers citing papers by Andrew Remppis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Remppis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Remppis. The network helps show where Andrew Remppis may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Andrew Remppis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andrew Remppis Line = papers co-authored together Andrew Remppis links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Künstliche Intelligenz in der Kardiologie: Relevanz, aktuelle Anwendungen und nächste Schritte Herzschrittmachertherapie + Elektrophysiologie ·Bettina Zippel‐Schultz, Carsten Schultz, Dirk Müller‐Wieland, Andrew Remppis, Martin Stockburger, Christian Perings, Thomas M. Helms	2021	1
2	Antikoagulation bei Patienten mit chronischer Niereninsuffizienz : Empfehlungen der Arbeitsgemeinschaft "Herz Niere" der Deutschen Gesellschaft für Kardiologie Herz- und Kreislaufforschung und der Deutschen Gesellschaft für Nephrologie. Der Internist ·Georg Schlieper, Vedat Schwenger, Andrew Remppis, Till Keller, Ralf Dechend, Steffen Maßberg, Stephan Baldus, Thomas Weinreich, Gerd R. Hetzel, Jürgen Floege, Felix Mahfoud, Danilo Fliser	2017	2
3	Nierenersatzverfahren bei therapierefraktärer Herzinsuffizienz Der Internist ·Vedat Schwenger, Andrew Remppis	2012	3
4	The Association Between Long-Term Longitudinal Trends in Guideline Adherence and Mortality in Relation to Age and Sex European Journal of Heart Failure ·Lutz Frankenstein, Andrew Remppis, Riad Mahbub, Andreas Doesch, Hugo A. Katus, Jochen Senges, Christian Zugck	2010	24
5	HMGB1: the missing link between diabetes mellitus and heart failure Basic Research in Cardiology ·H. Christian Volz, Irene Ferchl, Danai Laohachewin, Ziya Kaya, Oliver J. Müller, Sven T. Pleger, Felix Lasitschka, Marco E. Bianchi, Andrew Remppis, Angelika Bierhaus, Hugo A. Katus, Martin Andrassy	2010	103
6	Prevalence and Prognostic Significance of Adrenergic Escape During Chronic β-Blocker Therapy in Chronic Heart Failure European Journal of Heart Failure ·Lutz Frankenstein, Christian Zugck, Dieter Schellberg, Manfred Nelles, Pascal Molle, Hugo A. Katus, Andrew Remppis	2009	11
7	Staged Heart Transplantation and Chemotherapy as a Treatment Option in Patients with Severe Cardiac Light-Chain Amyloidosis European Journal of Heart Failure ·Arnt V. Kristen, Falk‐Udo Sack, Stefan Schönland, Ute Hegenbart, Burkhard Helmke, Achim Koch, Philipp A. Schnabel, Christoph Röcken, Stefan E. Hardt, Andrew Remppis, Hartmut Goldschmidt, Matthias Karck, Anthony D. Ho, Hugo A. Katus, Thomas J. Dengler	2009	37
8	S100A1 in cardiovascular health and disease: Closing the gap between basic science and clinical therapy Journal of Molecular and Cellular Cardiology ·Hiroki Tomozawa, David Rohde, M.A. Queralt, Gang Qiu, Sven T. Pleger, Mirko Voelkers, Melanie Boerries, Andrew Remppis, Hugo A. Katus, Patrick Most	2009	70
9	Primary ICD-therapy in patients with advanced heart failure: selection strategies and future trials Clinical Research in Cardiology ·Lutz Frankenstein, Christian Zugck, Manfred Nelles, Dieter Schellberg, Andrew Remppis, Hugo A. Katus	2008	10
10	Stable Myocardial-Specific AAV6-S100A1 Gene Therapy Results in Chronic Functional Heart Failure Rescue Circulation ·Sven T. Pleger, Patrick Most, Matthieu Boucher, Stephen Soltys, J. Kurt Chuprun, Tuija Lukkari, Erhe Gao, Abhijit Dasgupta, Giuseppe Rengo, Andrew Remppis, Hugo A. Katus, Andrea D. Eckhart, Joseph E. Rabinowitz, Walter J. Koch	2007	139
11	Beta-Blockers Influence the Short-term and Long-term Prognostic Information of Natriuretic Peptides and Catecholamines in Chronic Heart Failure Independent From Specific Agents The Journal of Heart and Lung Transplantation ·Lutz Frankenstein, Manfred Nelles, Frants Ol, Dieter Schellberg, Andreas Doesch, Hugo A. Katus, Andrew Remppis, Christian Zugck	2007	8
12	A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A—Containing and cyclosporin A—Free immunosuppressive regimens Clinical Therapeutics ·Andreas Dösch, Philipp Ehlermann, Achim Koch, Andrew Remppis, Hugo A. Katus, Thomas J. Dengler	2006	19
13	Immediate and chronic effects of AV-delay optimization in patients with cardiac resynchronization therapy International Journal of Cardiology ·Stefan E. Hardt, JANET RISCH, Alexander T. Bauer, Arthur Filusch, Grigorios Korosoglou, Alexander Hansen, Raffi Bekeredjian, Philipp Ehlermann, Andrew Remppis, Hugo A. Katus, Helmut F. Kuecherer	2006	40
14	Expression of Platelet-Derived Growth Factor and Fibroblast Growth Factor in Cryopreserved Endomyocardial Biopsies Early and Late After Heart Transplant The Annals of Thoracic Surgery ·Achim Koch, Adrian Nichole E. Colaste, Nikolaus Gaßler, Thomas J. Dengler, Andrew Remppis, Maria Pritsch, Falk‐Udo Sack, Siegfried Hagl, Philipp A. Schnabel	2006	4
15	Cardiac adenoviral S100A1 gene delivery rescues failing myocardium Journal of Clinical Investigation ·Patrick Most, Sven T. Pleger, Mirko Völkers, Adel Ali, Melanie Boerries, Dieter Weichenhan, Eva Löffler, Paul M.L. Janssen, Andrea D. Eckhart, Jeffrey Martini, Matthew Williams, Hugo A. Katus, Andrew Remppis, Walter J. Koch	2004	14
16	Cardiac adenoviral S100A1 gene delivery rescues failing myocardium Journal of Clinical Investigation ·Patrick Most, Sven T. Pleger, Mirko Völkers, Adel Ali, Melanie Boerries, Dieter Weichenhan, Eva Löffler, Paul M.L. Janssen, Andrea D. Eckhart, Jeffrey S. Martini, Matthew L. Williams, Hugo A. Katus, Andrew Remppis, Walter J. Koch	2004	159
17	Papillarmuskelruptur nach Herzkontusion Zeitschrift für Kardiologie ·Philipp Ehlermann, Andrew Remppis, Hugo A. Katus	2004	2
18	Purification of the Ca2+-binding protein S100A1 from myocardium and recombinant Escherichia coli Journal of Chromatography B Biomedical Sciences and Applications ·Philipp Ehlermann, Andrew Remppis, Patrick Most, Karen C Lindner, Claus W. Heizmann, Hugo A. Katus	2000	12
19	Altered expression of the Ca2+-binding protein S100A1 in human cardiomyopathy Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Andrew Remppis, 達雄畔柳, Beat W. Schäfer, Peter Hunziker, Paul Erné, Hugo A. Katus, Claus W. Heizmann	1996	136
20	Troponin T: A diagnostic marker for myocardial infarction and minor cardiac cell damage European Heart Journal ·E. Nesterina, Tim F. Greten, Margit Müller-Bardorff, Andrew Remppis, Jörg Zehelein, Ekkehard Grünig, Hugo A. Katus	1996	60

About Andrew Remppis

Andrew Remppis is a scholar working on Cardiology and Cardiovascular Medicine, Family Practice, Health Informatics, Transplantation and Complementary and alternative medicine, having authored 102 papers that have together received 6.1k indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (31 papers), S100 Proteins and Annexins (20 papers), Cardiac electrophysiology and arrhythmias (19 papers), Cardiac pacing and defibrillation studies (14 papers), Transplantation: Methods and Outcomes (9 papers), Protease and Inhibitor Mechanisms (9 papers), Acute Myocardial Infarction Research (9 papers) and Cardiovascular Effects of Exercise (8 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (3.9k citations), Clinical Biochemistry (467 citations), Radiology, Nuclear Medicine and Imaging (987 citations), Internal Medicine (106 citations) and Molecular Biology (1.9k citations). Andrew Remppis has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Hugo A. Katus, Thomas Scheffold, K W Diederich, Wolfgang M. Kuebler, Patrick Most, Sven T. Pleger, Walter J. Koch, Margit Müller-Bardorff, A. Borgya and Klaus Hallermayer. Their work appears in journals such as Clinical Research in Cardiology, Circulation, Clinical Chemistry, European Heart Journal and International Journal of Cardiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact